Clinical features and growth fractions of pituitary adenomas

Surgical Neurology

Volumn 48, Issue 5, 1997, Pages 494-500

  Yonezawa, Kazuki ^a   Tamaki, Norihiko ^a   Kokunai, Takashi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Growth fraction; Invasion recurrence; MIB 1; Pituitary adenoma

Indexed keywords

FOLLITROPIN; GADOLINIUM PENTETATE; GROWTH HORMONE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROLACTIN;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CONTRAST ENHANCEMENT; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH;

EID: 0030722886     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(97)00102-X     Document Type: Article

References (27)

1. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells application to surgical neuropathology . Am J Surg Pathol. 10:1986;611-617.
2. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 168:1992;357-363.
3. Davis PC, Hoffman JA, Malko JA, Tindall GT, Takei Y, Avruch L, Braun IF. Gadolinium-DTPA and MR imaging of pituitary adenoma. AJNR. 8:1987;817-823.
4. Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg. 64:1986;713-719.
5. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol. 133:1984;1710-1715.
6. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 138:1991;867-873.
7. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl). 74:1987;179-182.
8. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors a study with MIB 1 monoclonal antibody on archival material . Acta Neuropathol. 84:1994;47-54.
9. Kitz K, Knosp E, Koos WTH, Korn A. Proliferation in pituitary adenomas measurement by MAb Ki-67 . Acta Neurochir (Wien). 53:(Suppl):1991;60-64.
10. Knosp E, Kitz K, Perneczky A. Proliferation activity in pituitary adenomas measurement by monoclonal antibody Ki-67 . Neurosurgery. 25:1989;927-930.
11. Knosp E, Kitz K, Steiner E, Matula CH. Pituitary adenomas with parasellar invasion. Acta Neurochir (Wien). 53:(Suppl):1991;65-71.
12. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space a magnetic resonance imaging classification compared with surgical findings . Neurosurgery. 33:1993;610-618.
13. Landolt AM, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg. 67:1987;803-806.
14. Lucas-Morante T, Garcia-Uria J, Estrada J, Saucedo G, Cabello A, Alcaniz J, Barcelo B. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. J Neurosurg. 81:1994;10-14.
15. Miki Y, Matsuo M, Nishizawa S, Kuroda Y, Keyaki A, Makita Y, Kawamura J. Pituitary adenomas and normal pituitary tissue enhancement patterns in gadopentetate-enhanced MR imaging . Radiology. 177:1990;35-38.
16. Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery. 36:1995;259-269.
17. Moriura T, Kitz K, Budka H. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labelling technique and proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol. 77:1989;276-282.
18. Nagashima T, Murovic JA, Hoshino T, Wilson CB, Dearmond SJ. The proliferative potential of human pituitary tumors in situ. J Neurosurg. 64:1986;588-593.
19. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res. 8:1988;534-544.
20. Sassolas G, Harris AG, James-Deider A. Long term effect of incremental doses of the somatostatin analog SMS 201-995 approximately equal to Acromegaly Study Group. J Clin Endocrinol Metab. 71:1990;391-397.
21. Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg. 65:1986;733-744.
22. Scotti G, Yu CY, Dilon WP, Norman D, Colombo N, Newton TH, De Groot J, Wilson CB. MR imaging of cavernous sinus involvement by pituitary adenomas. AJNR. 9:1988;657-664.
23. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase α monoclonal antibodies, and nucleolar organizer region counts. Acta Neuropathol. 84:1992;178-183.
24. Shi YF, Harris AG, Zhu XF, Deng JY. Clinical and biochemical effects of incremental doses of the long-acting somatostatin analogue SMS 201-995 in ten acromegalic patients. Clin Endocrinol. 32:1990;695-705.
25. Shi RR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39:1991;741-748.
26. Vlahovitch B, Reynaud C, Rhiati J, Mansour H, Hammoud F. Treatment and recurrences in 135 pituitary adenomas. Acta Neurochir (Wien). 42:(Suppl):1988;120-123.
27. Zuber P, Hamou MF, de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery. 22:1988;364-368.